TABLE 2

Data on SUVmax

GroupTotal number of lesionsLesions measuredAverage SUVmax at baselineAverage SUVmax at follow-upAverage increase in SUVmax (%)
Group A
 11327.112.171
 2658.812.875
 31116.712.3−26
 4433.84.422
 5115.312.8142
 61468.77.0−17
 7336.27.623
 8446.35.3−16
 91869.99.91
 10437.26.20
 Mean increase in SUVmax38%
Group B
 11325.96.49
 12335.64.4−23
 13115.46.011
 144211.515.843
 15667.68.313
 16117.82.3−57
 17225.213.7179
 18112.21.6−27
 19111.71.6−6
 20115.44.5−17
 21225.65.1−4
 Mean increase in SUVmax−11%
  • Patients 3, 9, and 14 were excluded from further analyses because initial SUVmax for most metastatic lesions was >10. Patient 17 was excluded because second liver metastasis developed just adjacent to first metastasis, making measurement of separate SUVs impossible.